John-Peter Zak

John-Peter Zak is a highly experienced professional in risk management and pharmacovigilance, currently serving as Senior Director of Risk Management-REMS at AstraZeneca since May 2025. Prior to this role, John-Peter held the position of Director of Pharmacovigilance and Risk Management at BioNTech SE from November 2023 to May 2025. John-Peter has also contributed to the pharmaceutical industry as Medical Director of Medical Safety Science at Apellis Pharmaceuticals and as Associate Director at Johnson & Johnson Innovative Medicine. Additional experience includes significant roles at Novartis, Celgene, Mandell's Clinical Pharmacy, APCER Life Sciences, Pharmedium, and Walgreens. John-Peter holds a Doctor of Pharmacy (Pharm.D.) degree from Rutgers University, which was completed in 2007.